Teeing Up Against Brain Cancer
In 2008 at the age of 40, Melissa Pittman wasn’t thinking about
cancer – busy with an active family, Melissa and her husband,
Jay, had become part of the East Lake Woodlands Country Club
golf community when they relocated from South Carolina.
Suddenly, Melissa and her family were faced with a shocking
diagnosis – an inoperable brain tumor – and her life was forever
changed. Initially given just three years to live, Melissa began
her journey to survive. With chemo and radiation treatments
to keep the tumor from growing, Melissa continued to beat
the odds for eight unimaginable years. Early in 2016 the tumor
again began to grow and Melissa lost her battle that spring.
But her inspiration to find a cure lives on and remains the
focus of our foundation.
Melissa’s determination, fighting spirit and the support of
many friends and colleagues in the golfing community are
Neuro-Oncology Active Clinical Trials
the inspiration for Golfers vs. Brain Cancer. Family, friends, golfers
of all skill levels – have rallied on behalf of Melissa and so many
others who are stricken with brain cancer.
Golfers Vs. Brain Cancer Foundation, a501(c) 3
non-profit corporation whose goal is finding a
cure for brain cancer, hosted the ninth annual
Golfers Vs Brain Cancer Golf Tournament
on Friday, November 17, 2017 at the
East Lake Woodlands Country Club.
But you can still help the cause.
If you’d like to donate to the Golfers vs.
Brain Cancer Foundations, you can do so on
their website, http://www.golfersvsbraincancer.com.
You can also follow them on Twitter and on Facebook.
Trial Name MCC # Grade Prior Treatment
Y/N
Contact for
Eligibility Criteria
Recurrent Gliomas
A Phase 3, Randomized, Open-Label Study To Evaluate the Effi cacy and
Safety of Efl ornithine with Lomustine Compared to Lomustine Alone
in Patients with Anaplastic Astrocytoma That Progress/Recur After
Irradiation and Adjuvant Temozolomide Chemotherapy
18778 3 Y Forsyth
A Phase 2/3 Randomized, Open-Label Study of Toca 511, a Retroviral
Replicating Vector, Combined With Toca FC versus Standard of Care
in Subjects Undergoing Planned Resection for Recurrent Glioblastoma
or Anaplastic Astrocytoma
18576 3,4 Y Tran
Phase I Trial of Hypofractionated Stereotactic Irradiation (HFSRT)
Combined with Nivolumab, Ipilimumab and Bevacizumab in Patients
with Recurrent High Grade Gliomas
18661 3,4 Y Sahebjam
A Randomized Phase 2 trial of Cediranib and Olaparib Compared to
Bevacizumab in Patients with Recurrent Glioblastoma who have not
Received Prior VEGF Therapy.
19385 4 Y Sahebjam
Newly Diagnosed Malignant Glioma
A Phase II/III Randomized Trial of Veliparib or Placebo in Combination
with Adjuvant Temozolomide in Newly Diagnosed Glioblastoma with
MGMT Promoter Hypermethylation
18308 4 N Forsyth
A Randomized Phase 3 Single Blind Study of Temozolomide
plus Radiation Therapy combined with Nivolumab or Placebo in
Newly Diagnosed Adult Subjects with MGMT-Methylated
(tumorO6-methylguanine DNA methyltransferase) Glioblastoma
18647 4 N Sahebjam
A Phase I Trial of Pembrolizumab and Vorinostat
Combined with Temozolomide and Radiation Therapy
for Newly Diagnosed Glioblastoma
19342 4 N Sahebjam
Meningiomas
Phase II Trial of SMO/AKT/NF2 Inhibitors in Progressive Meningiomas
With SMO/AKT/NF2 Mutations
18660 1-3 N Forsyth
continues on page 15
14 NEURON NEWS | 2018 ISSUE MOFFITT.org
/www.golfersvsbraincancer.com
/MOFFITT.org